INVICTUS MD STRATEGIES CORP. announced that the Company's Board of Directors has approved the appointment of Keith Stein, Counsel at Dentons Canada LLP ("Dentons"), to serve on the Board effective January 11, 2019. The new appointment follows the resignations of Trevor Dixon, President and Director of Invictus since April 25, 2017, and Josef Hocher, member of the Board since June 26, 2017. Mr. Dixon will remain as President and Director of the Company's wholly-owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms"). George E. Kveton, CEO of Invictus will assume the role of President of the Company. Mr. Stein joined Dentons as Counsel in 2014 after serving as Counsel at Heenan Blaikie LLP from 2008 until February 2014.